Cortes, J., Lipton, J., Kota, V., Castagnetti, F., Assouline, S., Brummendorf, T., et al. (2023). Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. HAEMATOLOGICA, 108(12), 3454-3459 [10.3324/haematol.2022.281944].

Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

Gambacorti-Passerini C.
2023

Lettera in rivista
Cross-intolerance, bosutinib, leukemia, tyrosine kinase inhibitors
English
1-dic-2023
2023
108
12
3454
3459
none
Cortes, J., Lipton, J., Kota, V., Castagnetti, F., Assouline, S., Brummendorf, T., et al. (2023). Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. HAEMATOLOGICA, 108(12), 3454-3459 [10.3324/haematol.2022.281944].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/472977
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
Social impact